CClinicalTrials.gg
CompletedNCT03566888Updated Nov 8, 2018

Validation of a Noninvasive Automated Blood Pressure Device

An observational study in Blood Pressure, sponsored by University of Southern California. Completed at 1 site in United States. Open to participants aged 12 Years to 92 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-08.

Sponsored by University of Southern California · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
85
Ages
12 Years to 92 Years
Sex
All
01

Study summary

The investigator's objective is to validate the novel automated blood pressure device against the requirements set forth in the AAMI_ISO 81060-2:2010 standard in voluntarily consented study participants.

Read the detailed description

A new prototype blood pressure cuff has been designed for the higi SH llc health stations. This new cuff accurately captures blood pressure (BP) by emulating a fitted cuff which is used in conjunction with a mercury sphygmomanometer, the accepted gold standard for measuring BP values in most clinical facilities. The cuff is driven by a motor and gearhead to automatically "wrap" the cuff around a user's arm when they initiate a BP test. A BP measurement is then taken by an Original Equipment Manufacturer (OEM) BP module using an algorithm developed for use with a fitted cuff; the same module one would expect to find in a clinic or doctor's office. For the device to pass the AAMI_ISO 81060-2:2010 standard statistical requirements and thus, be considered a valid device for measuring BP it will need to meet the standards criteria 1 and 2.

02

Conditions studied

  • Blood Pressure
03

In context

Lead sponsor

University of Southern California is the lead sponsor of 773 studies on the registry; 135 are open to participants now.

Of its 68 completed or terminated interventional studies of FDA-regulated products, 32 (47%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 92 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals between the ages of 12-92 years, generally healthy, and have not been diagnosed with heart disease.

Inclusion criteria

  • between the ages of 12 to 92 years of age.
  • generally healthy but can be on medication for blood pressure regulation.

Exclusion criteria

Exclusion Criteria:

  • heart disease is present such as, coronary artery disease, cardiomegaly, irregular heart rhythm, atrial fibrillation, heart valve disease, congenital heart disease, cardiomyopathy, pericardial effusion, Marfan syndrome, and heart murmurs.
  • using a pacemaker to maintain a suitable heart rate.
  • missing their natural left arm.
  • exhibit a musculoskeletal disorder that may prevent them from sitting upright for a period of time (\~40min) or prevent a BP reading taken from the left arm.
  • Special populations, for example pregnant women and patients with known arrhythmias.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
85 participants (actual)
Patient registry
No

Groups and cohorts

  • Single Group

    85 eligible study participants

    Device: Blood pressure assessment

Interventions

  • DeviceBlood pressure assessment

    Validation of an automated blood pressure device

06

What researchers measure

Primary outcomes

  1. Systolic and Diastolic blood pressure (criteria 1 and 2)

    Mean value of the differences of the paired (i.e., device under test - reference method) determinations for all study participants shall be within or equal to ± 5 mmHg with a standard deviation no greater than 8 mmHg (criterion 1). Standard deviation of the averaged paired determinations per participant shall meet the criterion 2 listed in the standard.

    Time frame: 60 minutes

07

Study locations

1 site
  • University of Southern California
    Los Angeles, California 90033, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03566888
Lead sponsor
University of Southern California
Responsible party
Todd Schroeder (Assistant Professor, University of Southern California) — Principal investigator
First posted
Jun 25, 2018
Start date
Aug 1, 2017
Primary completion
Oct 2, 2018
Completion
Oct 2, 2018
Last update
Nov 8, 2018

Study contacts

Todd Schroeder, PhD
principal investigator · University of Southern California

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion